Skip to content

Survey on Treatment pattern in Chinese advanced Endometrial cancer who are Progressed on platinum treatment (STEP)

Survey on Treatment pattern in Chinese advanced Endometrial cancer who are Progressed on platinum treatment (STEP)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090397
Enrollment
Unknown
Registered
2024-09-29
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced Endometrial cancer

Interventions

Sponsors

Guangdong Second Provincial General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 99 Years

Inclusion criteria

Inclusion criteria: The physicians who meet the following eligibility criteria will be included: 1)Must obtain a Medical Certificate and a Medical Practitioner Certificate specializing in oncology, radiation oncology/therapeutic radiology or gynecology 2)Must hold a designation of attending physician or above (Phase 1)/Must hold a designation of chief physician (Phase 2) 3)At least 5 years’ experience in managing EC patients 4)In the past 6 months, must treat and manage at least 15 EC patients (medical oncologists and radiologists)/at least 20 EC patients (gynecologists) 5)In the past 6 months, must treat and manage at least 1 advanced EC patients who had disease progression or recurrence following platinum-based chemotherapy 6)Main decision maker or part of the team that makes the decision regarding treatment prescription for EC (pharmaceutical therapy/immunotherapy and/or radiotherapy) 7)Provide informed consent All inclusion and exclusion criteria will be reviewed by the investigator or qualified designee to ensure that the subject qualifies for the study.

Exclusion criteria

Exclusion criteria: Unable or unwilling to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Patient characteristic;Treatment patterns;

Secondary

MeasureTime frame
EC biomarker;Physicians' perspectives on EC treatment decisions;

Countries

China

Contacts

Public ContactXianghong Ou

Guangdong Second Provincial General Hospital

ouxianghong2003@163.com+86 139 2516 7065

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026